Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

CRISIS survey offers better insights into the psychological and physical impact of COVID-19

To better understand the psychological and physical impact caused by the profound consequences of the COVID-19 pandemic - and also inform priorities for interventions and policy changes to address the mental health consequences of the pandemic.

16 Apr 2021

A new approach to estimate the risks of exposure to COVID-19 under different indoor settings

Two MIT professors have proposed a new approach to estimating the risks of exposure to Covid-19 under different indoor settings.

16 Apr 2021

Analysis: Hispanic, Black, and Native Americans have carried the burden of COVID-19 pandemic

A UCLA Fielding School of Public Health-led team has found that Hispanic, Black, and Native Americans have carried the burden of the pandemic, both in overall mortality and specifically in years of potential life lost, in an analysis of 45 U.S. states and the District of Columbia (D.C.).

16 Apr 2021

Researchers explore ways to reduce firearm-related death and injury

Fifty-five years ago, America's death toll from automobile crashes was sky-high. Nearly 50,000 people died every year from motor vehicle crashes, at a time when the nation's population was much smaller than today.

16 Apr 2021

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

A number of SARS-CoV-2 variants have emerged from immunocompromised hosts, research has identified. It is thought that variants of concern - including B.1.1.7, a variant first identified in Kent - were a result of long-term infection in people with a weakened immune system.

16 Apr 2021

COVID-19 pandemic limits access to opioid dependency treatment, increases overdose deaths

COVID-19 has been associated with increases in opioid overdose deaths, which may be in part because the pandemic limited access to buprenorphine, a treatment used for opioid dependency, according to a new study led by Princeton University researchers.

16 Apr 2021

New model for making accurate short-term projections of COVID-19 cases

A new study by Texas A&M University researchers published in PLOS ONE details a new model for making short-term projections of daily COVID-19 cases that is accurate, reliable and easily used by public health officials and other organizations.

16 Apr 2021

Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection

By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka and the United Kingdom have found that more than 90% of vaccinated individuals produced an adequate amount of antibodies after receiving only one dose of the vaccine – irrespective of their age and gender.

16 Apr 2021

Study evaluates the impact of alternative payment schedules to mitigate drug-related harms

A study published this week in The Lancet Public Health examines how we can use our income assistance systems to address drug use and drug-related harm.

16 Apr 2021

Remote and virtual health care models can negatively impact small physician offices

In a newly released study, researchers found that remote and virtual care models can negatively impact small physician offices.

16 Apr 2021

Epigenetic endowment of every person has an impact on COVID-19 severity

COVID-19, caused by the infection of the SARS-CoV-2 virus, has changed people's behavioral patterns since the moment it became a global pandemic.

15 Apr 2021

COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants

Researchers in the United States have demonstrated the efficacy of the vaccine INO-4800 against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

15 Apr 2021

Chile and Uruguay are experiencing their worst moment of COVID-19 pandemic

Chile and Uruguay emerged as model cases last year for their handling of the COVID-19 crisis and are among the top five countriesin the world with the most vaccine doses administered per 100 people daily.

15 Apr 2021

Feline model of SARS-CoV-2 infection imitates COVID-19 in humans

Researchers in the United States have validated a feline model of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that closely imitates coronavirus disease 2019 (COVID-19) in humans.

15 Apr 2021

Obese or overweight patients at high risk for having worse COVID-19 outcomes

Patients who are overweight or obese have more severe COVID-19 and are highly likely to require invasive respiratory support, according to a new international study.

15 Apr 2021

COVID-19 pandemic has worsened global maternal and perinatal outcomes

Immediate action is required to preserve safe maternity care worldwide, as the COVID-19 pandemic worsens global maternal and perinatal outcomes, especially in low- and middle- income countries (LMICs), a study warns.

15 Apr 2021

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research.

15 Apr 2021

CUNY SPH announces the New York State Vaccine Education and Adoption Project

In a race to transform the vaccine-hesitant into adopters in New York City and surrounding counties as Covid-19 variants rise, the CUNY Graduate School of Public Health and Health Policy has announced the New York State Vaccine Education and Adoption Project.

15 Apr 2021

Researchers develop “Nano-Glue” with therapeutic potential against SARS-CoV-2

In a recent study, researchers target the electropositive receptor-binding domain (RBD) on the SARS-CoV-2 spike protein with the abundant β-sheet structure as a novel COVID-19 therapeutic drug design.

15 Apr 2021

Keele researcher awarded prestigious grant to identify treatments for devastating childhood disease

A Keele researcher will embark on a two-year study to identify affordable treatments to help children living with spinal muscular atrophy.

15 Apr 2021

Pandemic News and Research

Further Reading

CRISIS survey offers better insights into the psychological and physical impact of COVID-19

A new approach to estimate the risks of exposure to COVID-19 under different indoor settings

Analysis: Hispanic, Black, and Native Americans have carried the burden of COVID-19 pandemic

Researchers explore ways to reduce firearm-related death and injury

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

COVID-19 pandemic limits access to opioid dependency treatment, increases overdose deaths

New model for making accurate short-term projections of COVID-19 cases

Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection

Study evaluates the impact of alternative payment schedules to mitigate drug-related harms

Remote and virtual health care models can negatively impact small physician offices

Epigenetic endowment of every person has an impact on COVID-19 severity

COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants

Chile and Uruguay are experiencing their worst moment of COVID-19 pandemic

Feline model of SARS-CoV-2 infection imitates COVID-19 in humans

Obese or overweight patients at high risk for having worse COVID-19 outcomes

COVID-19 pandemic has worsened global maternal and perinatal outcomes

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

CUNY SPH announces the New York State Vaccine Education and Adoption Project

Researchers develop “Nano-Glue” with therapeutic potential against SARS-CoV-2

Keele researcher awarded prestigious grant to identify treatments for devastating childhood disease

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News